DexCom, Inc. (DXCM)

87.90 -1.81 (-2.02%) USD  |  NASDAQ  |  Sep 04, 16:00
88.09 +0.19 (+0.22%) After-Hours: 20:00
More

DexCom SG&A Expense (TTM) : 1.361B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for DXCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 1.361B
March 31, 2026 1.331B
December 31, 2025 1.291B
September 30, 2025 1.297B
June 30, 2025 1.272B
March 31, 2025 1.277B
December 31, 2024 1.286B
September 30, 2024 1.267B
June 30, 2024 1.246B
March 31, 2024 1.210B
December 31, 2023 1.185B
September 30, 2023 1.174B
June 30, 2023 1.124B
March 31, 2023 1.076B
December 31, 2022 1.002B
September 30, 2022 938.10M
June 30, 2022 902.00M
March 31, 2022 839.60M
December 31, 2021 807.30M
September 30, 2021 749.50M
June 30, 2021 709.60M
March 31, 2021 659.50M
December 31, 2020 620.70M
September 30, 2020 573.80M
June 30, 2020 539.40M
Date Value
March 31, 2020 541.30M
December 31, 2019 515.70M
September 30, 2019 498.80M
June 30, 2019 479.20M
March 31, 2019 452.20M
December 31, 2018 432.80M
September 30, 2018 413.50M
June 30, 2018 393.10M
March 31, 2018 367.60M
December 31, 2017 349.20M
September 30, 2017 335.50M
June 30, 2017 327.00M
March 31, 2017 310.50M
December 31, 2016 286.20M
September 30, 2016 268.20M
June 30, 2016 244.80M
March 31, 2016 220.70M
December 31, 2015 198.00M
September 30, 2015 173.10M
June 30, 2015 154.50M
March 31, 2015 140.20M
December 31, 2014 128.40M
September 30, 2014 116.00M
June 30, 2014 103.90M
March 31, 2014 93.70M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 13.94B
Insulet Corp. 1.309B
Baxter International, Inc. 2.932B
Globus Medical, Inc. 1.217B
Stryker Corp. 8.782B